Elaine B Cadogan (Elaine Cadogan)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Science translational medicine

PLoS biology

AstraZeneca UK Ltd

This page only lists publications with an associated author ORCID identifier.

Affiliation History

AstraZeneca UK Ltd

United Kingdom

Associate Director :: Bioscience

Publications

Sandra Wimberger, Nina Akrap, Mike Firth, Johan Brengdahl, Susanna Engberg, Marie K Schwinn, Michael R Slater, Anders Lundin, Pei-Pei Hsieh, Songyuan Li, Silvia Cerboni, Jonathan Sumner, Burcu Bestas, Bastian Schiffthaler, Björn Magnusson, Silvio Di Castro, Preeti Iyer, Mohammad Bohlooly-Y, Thomas Machleidt, Steve Rees, Ola Engkvist, Tyrell Norris, Elaine B Cadogan, Josep V Forment, Saša Šviković, Pinar Akcakaya, Amir Taheri-Ghahfarokhi, Marcello Maresca
Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editing. Nature communications 14 (1) (2023)
Audrey Laroche-Clary, Coralie Josensi, Marie-Alix Derieppe, Sarah Belhomme, Véronique Vendrely, Raul E Perret, Elaine B Cadogan, Antoine Italiano
Selective DNA-PK inhibition enhances chemotherapy and ionizing radiation activity in soft-tissue sarcomas. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Violeta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, Urszula M Polanska, Marta Palafox, Andrea Herencia-Ropero, Gemma N Jones, Zhongwu Lai, Joshua Armenia, Filippos Michopoulos, Alba Llop-Guevara, Rachel Brough, Aditi Gulati, Stephen J Pettitt, Krishna C Bulusu, Jenni Nikkilä, Zena Wilson, Adina M Hughes, Paul W G Wijnhoven, Ambar Ahmed, Alejandra Bruna, Albert Gris-Oliver, Marta Guzman, Olga Rodríguez, Judit Grueso, Joaquín Arribas, Javier Cortes, Cristina Saura, Alan Lau, Susan E Critchlow, Brian Dougherty, Carlos Caldas, Gordon B Mills, J Carl Barrett, Josep V Forment, Elaine B Cadogan, Christopher J Lord, Cristina Cruz, Judith Balmaña, Lenka Oplustil O'Connor
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Alessia Anastasia, Giulia Dellavedova, Antonio Ramos-Montoya, Neil James, Giovanna Chiorino, Massimo Russo, Hana Baakza, Joanne Wilson, Carmen Ghilardi, Elaine B Cadogan, Raffaella Giavazzi, Maria Rosa Bani
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases. Molecular cancer therapeutics 21 (4) (2022)
Dharaminder Singh, Sudhir P Deosarkar, Elaine B Cadogan, Vikki Flemington, Alysha Bray, Jingwen Zhang, Ronald S Reiserer, David K Schaffer, Gregory B Gerken, Clayton M Britt, Erik M Werner, Francis D Gibbons, Tomasz Kostrzewski, Christopher E Chambers, Emma J Davies, Antonio Ramos Montoya, Jacqueline H L Fok, David Hughes, Kristin Fabre, Matthew P Wagoner, John P Wikswo, Clay W Scott
A microfluidic system that replicates pharmacokinetic (PK) profiles in vitro improves prediction of in vivo efficacy in preclinical models. PLoS biology 20 (5) (2022)
Tudor Petreus, Elaine B Cadogan, Gareth Hughes, Aaron Smith, Venkatesh Pilla Reddy, Alan Lau, Mark James O'Connor, Susan Critchlow, Marianne B Ashford, Lenka Oplustil O'Connor
Tumour-on-chip microfluidic platform for assessment of drug pharmacokinetics and treatment response. Communications biology 4 (1) (2021)
Kyoko Nakamura, Ankur Karmokar, Paul M Farrington, Neil H James, Antonio Ramos-Montoya, Susan J Bickerton, Gareth D Hughes, Timothy M Illidge, Elaine B Cadogan, Barry R Davies, Simon J Dovedi, Viia Valge-Archer
Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Balakrishna Koneru, Ahsan S Farooqi, Thinh Hoang Nguyen, Wan Hsi Chen, Ashly Hindle, Cody Eslinger, Monish Ram Makena, Trevor A Burrow, Joanne Wilson, Aaron Smith, Venkatesh Pilla Reddy, Elaine B Cadogan, Stephen T Durant, C Patrick Reynolds
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156. Science translational medicine 13 (607) (2021)
Jacqueline H L Fok, Antonio Ramos-Montoya, Mercedes Vazquez-Chantada, Paul W G Wijnhoven, Valeria Follia, Neil James, Paul M Farrington, Ankur Karmokar, Sophie E Willis, Jonathan Cairns, Jenni Nikkilä, David Beattie, Gillian M Lamont, M Raymond V Finlay, Joanne Wilson, Aaron Smith, Lenka Oplustil O'Connor, Stephanie Ling, Stephen E Fawell, Mark J O'Connor, Simon J Hollingsworth, Emma Dean, Frederick W Goldberg, Barry R Davies, Elaine B Cadogan
AZD7648 is a potent and selective DNA-PK inhibitor that enhances radiation, chemotherapy and olaparib activity. Nature communications 10 (1) (2019)

Elaine B Cadogan.css-eqlu8i{font-size:small;padding-left:4px;} (Elaine Cadogan)

Publication Activity (10 Years)

Top Topics

Top Venues

Elaine B Cadogan (Elaine Cadogan)